The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Caitlin.Reilly@glasgow.ac.uk
Nuclear Medicine Dept. Queen Elizabeth University Hospital, 1345 Govan Rd, Glasgow, G51 4TF
Reilly, C., Gemmell, A. J. , McLaughlin, I. M., Fleming, R., Reed, N., McIntosh, D. and Nicol, A. (2021) Characterisation of 99mTc EDDA/HYNIC-TOC (Tektrotyd) physiological and neuroendocrine tumour uptake using SPECT/CT standardised uptake values: initial experience. Nuclear Medicine Communications, 42(8), pp. 935-939. (doi: 10.1097/mnm.0000000000001416) (PMID:33741866)
Reilly, C., Gemmell, A. J. , McLaughlin, I. M., Fleming, R., Reed, N., McIntosh, D. and Nicol, A. (2021) Characterisation of 99mTc EDDA/HYNIC-TOC (Tektrotyd) physiological and neuroendocrine tumour uptake using SPECT/CT standardised uptake values: initial experience. Nuclear Medicine Communications, 42(8), pp. 935-939. (doi: 10.1097/mnm.0000000000001416) (PMID:33741866)